Sylvie Courtois

617 total citations
12 papers, 225 citations indexed

About

Sylvie Courtois is a scholar working on Pathology and Forensic Medicine, Neurology and Infectious Diseases. According to data from OpenAlex, Sylvie Courtois has authored 12 papers receiving a total of 225 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pathology and Forensic Medicine, 5 papers in Neurology and 2 papers in Infectious Diseases. Recurrent topics in Sylvie Courtois's work include Multiple Sclerosis Research Studies (5 papers), Peripheral Neuropathies and Disorders (2 papers) and Poisoning and overdose treatments (2 papers). Sylvie Courtois is often cited by papers focused on Multiple Sclerosis Research Studies (5 papers), Peripheral Neuropathies and Disorders (2 papers) and Poisoning and overdose treatments (2 papers). Sylvie Courtois collaborates with scholars based in France, United Kingdom and Democratic Republic of the Congo. Sylvie Courtois's co-authors include G. Rodier, Clotilde Boulay, B. Monga, Denys Chaigne, Marie‐Céline Fleury, Jean‐Pierre Delaunoy, Christine Tranchant, Mathieu Anheim, François Sellal and M. Koenig and has published in prestigious journals such as Neurology, American Journal of Neuroradiology and Journal of Neurology.

In The Last Decade

Sylvie Courtois

9 papers receiving 221 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sylvie Courtois France 7 98 94 79 68 39 12 225
Christopher Uy Canada 6 62 0.6× 16 0.2× 136 1.7× 21 0.3× 54 1.4× 14 238
Asako Horino Japan 10 67 0.7× 43 0.5× 64 0.8× 20 0.3× 6 0.2× 24 251
Laura Planas‐Serra Spain 8 112 1.1× 19 0.2× 68 0.9× 8 0.1× 25 0.6× 10 298
Fatih Erdi Türkiye 12 90 0.9× 25 0.3× 100 1.3× 4 0.1× 14 0.4× 39 306
Mingfang Zhou China 9 75 0.8× 21 0.2× 70 0.9× 7 0.1× 52 1.3× 20 271
Deepa Krishnakumar United Kingdom 7 65 0.7× 20 0.2× 113 1.4× 9 0.1× 15 0.4× 15 187
Luigina Musu Italy 10 46 0.5× 11 0.1× 55 0.7× 33 0.5× 23 0.6× 10 299
Gianmarco Bellucci Italy 8 38 0.4× 14 0.1× 84 1.1× 27 0.4× 7 0.2× 18 213
Chen-Jui Ho Taiwan 9 48 0.5× 41 0.4× 22 0.3× 8 0.1× 10 0.3× 16 160
Hanène Benrhouma Tunisia 8 62 0.6× 25 0.3× 57 0.7× 5 0.1× 7 0.2× 37 150

Countries citing papers authored by Sylvie Courtois

Since Specialization
Citations

This map shows the geographic impact of Sylvie Courtois's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvie Courtois with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvie Courtois more than expected).

Fields of papers citing papers by Sylvie Courtois

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sylvie Courtois. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvie Courtois. The network helps show where Sylvie Courtois may publish in the future.

Co-authorship network of co-authors of Sylvie Courtois

This figure shows the co-authorship network connecting the top 25 collaborators of Sylvie Courtois. A scholar is included among the top collaborators of Sylvie Courtois based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sylvie Courtois. Sylvie Courtois is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Kremer, Laurent, et al.. (2025). Evolution of high-efficacy treatment strategy for relapsing-remitting multiple sclerosis: A real-life observational study. Multiple Sclerosis and Related Disorders. 104. 106690–106690.
2.
Kremer, Laurent, Marie Fleury, François Sellal, et al.. (2023). Early use of high efficacy therapies in pediatric forms of relapsing-remitting multiple sclerosis: A real-life observational study. Multiple Sclerosis and Related Disorders. 79. 104942–104942. 7 indexed citations
3.
Bigaut, Kévin, Laurent Kremer, Thibaut Fabacher, et al.. (2022). Ocrelizumab versus fingolimod after natalizumab cessation in multiple sclerosis: an observational study. Journal of Neurology. 269(6). 3295–3300. 12 indexed citations
4.
Bigaut, Kévin, Thibaut Fabacher, Laurent Kremer, et al.. (2020). Long-term effect of natalizumab in patients with RRMS: TYSTEN cohort. Multiple Sclerosis Journal. 27(5). 729–741. 11 indexed citations
5.
Pop, Raoul, Anca Hasiu, Federico Bolognini, et al.. (2020). Stroke Thrombectomy in Patients with COVID-19: Initial Experience in 13 Cases. American Journal of Neuroradiology. 41(11). 2012–2016. 9 indexed citations
6.
Pop, Raoul, Véronique Quenardelle, Anca Hasiu, et al.. (2020). Impact of the COVID‐19 outbreak on acute stroke pathways – insights from the Alsace region in France. European Journal of Neurology. 27(9). 1783–1787. 67 indexed citations
7.
Beyrouti, Rahma & Sylvie Courtois. (2016). Parkinson Disease Associated with Myasthenia Gravis: A Case Report and Literature Review. Journal of Neurological Disorders. 4(4). 3 indexed citations
8.
9.
Berthe, Carole, Sylvie Courtois, Claude Gaultier, et al.. (2015). Prolonged-release Fampridine post-marketing experience in Alsace, France. (P1.126). Neurology. 84(14_supplement). 1 indexed citations
10.
11.
Rodier, G., et al.. (2000). CIGUATERA AND PERIPHERAL NEUROPATHY: A CASE REPORT. Journal of the Peripheral Nervous System. 5(4). 250–251. 3 indexed citations
12.
Rodier, G., et al.. (2000). CIGUATERA AND PERIPHERAL NEUROPATHY: A CASE REPORT. Journal of the Peripheral Nervous System. 5(4). 250–251. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christopher Uy Breakdown of academic impact, for papers by Asako Horino Breakdown of academic impact, for papers by Laura Planas‐Serra Breakdown of academic impact, for papers by Fatih Erdi Breakdown of academic impact, for papers by Mingfang Zhou Breakdown of academic impact, for papers by Deepa Krishnakumar Breakdown of academic impact, for papers by Luigina Musu Breakdown of academic impact, for papers by Gianmarco Bellucci Breakdown of academic impact, for papers by Chen-Jui Ho Breakdown of academic impact, for papers by Hanène Benrhouma
Rankless by CCL
2026